Is Archer-Daniels-Midland Stock Outperforming the Nasdaq? Archer-Daniels-Midland has notably outperformed the Nasdaq over the past year, but analysts are cautious about the stock’s prospects. Barchart · Sep 14
A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain? Abbott Laboratories' recent stock price dip contrasts with its strong Medical Devices division, creating a noteworthy opportunity for dividend investors. MarketBeat · Apr 7
These Are the 3 Top Oversold S&P 500 Stocks. Should You Buy the Dip? Abbott, Roper, and Humana are three blue-chip oversold stocks with significant upside potential for shareholders in January 2026. Barchart · Jan 29
Is Abbott’s January Pullback a Good Time to Buy? Abbott Laboratories' January price pullback is a signal to load up on shares; this Dividend Aristocrat is growing its business and driving cash flow. MarketBeat · Jan 24
Garmin just built its own version of MyFitnessPal inside Garmin Connect and it could change how you train Garmin’s new Nutrition feature brings calorie and macro tracking directly into Garmin Connect T3 · Jan 5
Is Archer-Daniels-Midland Stock Underperforming the Nasdaq? As Archer-Daniels-Midland has underperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain cautious about the stock’s prospects. Barchart · Jun 13, 2025
Reckitt sees sales slide after £100m tornado hit to baby formula The Nurofen-to-Dettol maker saw revenues dragged lower by a 17.4% tumble in sales at its nutrition division caused by tornado damage to a warehouse. Evening Standard · Oct 23, 2024
A big idea for small farms: How to link agriculture, nutrition and public health In Boulder, Colo., the county is investing in sustainable farming and helping people buy local produce. It's been called "a triple win" – for customers, farmers and the economy. WEKU · Feb 3, 2024
People Are Using ChatGPT for Nutrition Advice — The Results Are Dangerous When it comes to nutrition and diet, there’s a lot of information on the internet that may not be scientifically valid or applicable for humans. Inverse · Oct 31, 2023
Ready to run: Assessing protein needs for performance As you train for your upcoming distance race or other athletic event, you may be looking for ways to fine-tune your program and up your performance. Now's the time to take another look at what you're eating since nutrition is a key component of your training plan. Tribune News Service · May 25, 2023
Lawmakers steer toward food stamp clash on work requirements WASHINGTON — Lawmakers, as they work on the 2023 farm bill, are staking out positions on nutrition and food stamps — the Agriculture Department’s biggest single program and a perennial source of contention. Tribune News Service · Apr 18, 2023
Lawmakers steer toward food stamp clash on work requirements - Roll Call Food stamps are on course again to be a flash point in the farm bill as some Republicans want to add work requirements for recipients. Roll Call · Apr 18, 2023
Planning to Retire in 10 Years? Buy This Stock Now With an end to market volatility nowhere in sight, the strong fundamentals, stable prospects, and consistent income-generation potential of Archer-Daniels-Midland (ADM) merit its place in investors’ retirement portfolios. Read on…. StockNews.com · Mar 15, 2023
Cauliflower: A versatile nutrition superstar Like many consumers, you may be on a quest for healthier food options and willing to try something new or a new take on a familiar food. If you're diagnosed with celiac disease, you may be looking for gluten-free alternatives. Or maybe you're on the hunt for lower carbohydrate choices. Tribune News Service · Mar 10, 2023
Benzinga · Apr 26, 2022 Archer-Daniels-Midland Q1 Earnings Surpass Estimates Archer-Daniels-Midland Co (NYSE:ADM) reported first-quarter FY22 sales growth of 25.2% year-on-year to $23.65 billion, beating the consensus of $17.91 billion. Revenues from Ag Services and Oilseeds rose 21.6% Y/Y, Carbohydrate Solutions increased 51.4%, and Nutrition climbed 23%. The gross profit increased 22.5% Y/Y to $1.9 billion with a margin of 8%. The Segment…
Benzinga · Apr 21, 2022 What Does Raymond James, Wells Fargo Have To Say On Abbott's Q1 Earnings Raymond James thinks Abbott Laboratories' (NYSE: ABT) 1Q results were solid and demonstrated the durable nature of ABT's portfolio, as three out of four business segments grew over 10% organically, with Nutrition growing 8%